PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
Public ClinicalTrials.gov record NCT04079803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Biomarker and Safety Study of PTI-125 in Mild-to-moderate Alzheimer's Disease Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, Randomized, Double-blind, Placebo-controlled, multiple dose study of PTI-125 in mild-to-moderate Alzheimer's disease patients.
Study identification
- NCT ID
- NCT04079803
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2019 (Actual)
- Primary completion
- Mar 31, 2020 (Actual)
- Completion
- Mar 31, 2020 (Actual)
- Last update posted
- Sep 29, 2021
2019 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cognitive Clinical Trials | Gilbert | Arizona | 85296 | — |
| Cognitive Clinical Trials | Surprise | Arizona | 85374 | — |
| Optimus U | Miami | Florida | 33125 | — |
| IMIC, Inc. | Palmetto Bay | Florida | 33157 | — |
| Cognitive Clinical Trials | Bellevue | Nebraska | 68005 | — |
| Cognitive Clinical Trials | Omaha | Nebraska | 68116 | — |
| Advanced Memory Research Institute | Toms River | New Jersey | 08755 | — |
| Centex Studies, Inc. | Houston | Texas | 77058 | — |
| Centex Studies, Inc. | McAllen | Texas | 78504 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04079803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04079803 live on ClinicalTrials.gov.